Pharmaceutical sector first feels the heat of low margin
in the year of 2013 when Drug Price Control Order (DPCO) was introduced.
Before that high profit margins and MRP has attracted many other buisness
professionals into pharma
franchise sector. After Drug Price Control Order, PCD Pharma franchise sector started to change. At initial
stage about 348 important drugs has been taken under drug price control. After
that more and more drugs have been added in the price control slab. It is not
single factor that makes PCD Pharma buisness less lucrative. Under drug price
control good profit margin can be earned but many other factors are also
affceting and making hard to start PCD Pharma business.
Indian pharma companies are exporting generic medicines in
many countries and enjoying good profit margins in these countries that they
can not earn in India and other developing countries. India is largest exporter
of generic medicines to USA and earning high profit through USA market only but
recently price control by American market put Indian companies under pressure.
This pressure of price and margins may continue to other countries also.
Dependent on the export of only these countries is not easy and marginable now.
There are some other factors also affect growth and profit of pharma
franchise business, it is given as below:
Competition: This sector is one of the most competitive sector. A
single doctor is attending more than 10 medical representative on daily basis
and these numbers even increase at some area and segment. They all are visiting
for prescibing his company’s pharma
product. Sometime pharma
franchise companies make pressure to increase sales then sales
person try to convince doctor with any possible way (ethical or nonethical) to
complete his sales target. This high competitive environment makes harder
in pharma
market to start new business.
Strictness of Rules and Regulations: With the development of
sector, related rules and regulations become more strict with time to help
growth. Indian Pharmaceutical market is increasing rapidly and will be in
top position by 2020 but it still need improvement in standards according to
international market. There are many new regulations are introducing on regular
basis. Recently some new regulations are announced such as new pricing
authority, ethic codes for doctors, Plant specification should with WHO-GMP
standards etc.
International Price Control: With the increasing compliement of
price control in global market, Top Indian pharma companies also start to concentrate at
domestic market. This move become beneficial for domestic pharmaceutical market but at the same time it will make
situation more tougher and also increase competition at higher level
Online Pharma Portals: Currently this concept is not popular in
India but slowly and steadily it is making its presence in some parts and
becoming popular there. We cannot ignore power and reach of online pharmacy portals. It can affect whole distribution system
in pharmaceutical sector. Patients are accepting online pharmacies and In future it is going to become
important tool for selling pharma products .
Investment: Business starting cost is increasing day by day in
every sector. Profit is declining with the increment in investment. This makes
every business even PCD Pharma business though to start.
People are still enjoying doing business in the pharma
franchise sector and earning profit margins. For persons having
experience and knowledge in pharma
franchise sector, still it is lucrative and easy as it were be.
Looking
for pcd
pharma franchise opportunity and pharma
third party manufacturing feel free to contact us :
www.biopharlifesciences.co.in
